weight loss plateau on tirzepatide Plateau: 9 Reasons Progress Slows Why Am I Not Losing

Iron Deficiency Anemia: Microcytic Red Flag on the USMLE Iron deficiency anemia is the most common anemia worldwide and one of the first hematologic patterns youll need to recognize on Step 1 and Step 2

Its especially important when taking a long-term prescription, such as Mounjaro, a once-weekly injectable medication that treats Type 2 diabetes

Patients are too complicated

Flohe L, Otting F

In addition, a subpopulation of fibroblasts known as myofibroblasts produces the contractile protein alpha-smooth muscle actin (-SMA

The first GLP-1 drug, exenatide, was synthesized from exendin-4 , a peptide originally isolated from the saliva of the Gila monster lizard in the early 1990s and approved by the FDA in 2005.Over time, we got once-weekly versions (dulaglutide, semaglutide, etc.) and higher doses, which led to: Strong A1c lowering Substantial weight loss Cardiovascular benefits in high-risk patients with diabetes Where GLP-1s are clearly helpful Type 2 diabetes In type 2 diabetes, long-acting GLP-1 RAs: Lower A1c by roughly 11.5 percentage points Promote clinically meaningful weight loss Have low hypoglycemia risk Reduce heart attack and stroke in high-risk patients in multiple large trials For many with diabetes plus cardiovascular or kidney disease, a GLP-1 RA is now a core cardiometabolic drug , not just a glucose medication